3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
20
Lymphoma
5
Neoplasms, Plasma Cell
4
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Hodgkin Disease
2
Smoldering Multiple Myeloma
1
Sarcoma
1
Paraproteinemias
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Monoclonal Gammopathy of Undetermined Significance
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Immunoglobulin Light-chain Amyloidosis
1
Immunoblastic Lymphadenopathy
1
Hematologic Neoplasms
1
Disease
1
Carcinoma
1
Amyloidosis
1
Alzheimer Disease
1
Interventions
Dexamethasone
12
Bortezomib
9
Lenalidomide
6
Cyclophosphamide
5
isatuximab
3
fludarabine
3
daratumumab
3
Granulocyte Colony-Stimulating Factor
3
pomalidomide
2
filanesib
2
dacetuzumab
2
Tacrolimus
2
Steroids
2
Injections, Subcutaneous
2
Filgrastim
2
Clinical Protocols
2
Calcium Dobesilate
2
Alemtuzumab
2
plerixafor
1
nirogacestat
1
fludarabine phosphate
1
ficlatuzumab
1
birtamimab
1
Zoledronic Acid
1
Whole-Body Irradiation
1
Vorinostat
1
Tissue Banks
1
Thalidomide
1
Stem Cell Transplantation
1
Ranitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Paraproteinemias
×
Blood Specimen Collection
×
Plasma cell
×
Clear all
NCT01543100
2014-01-06
PACMoG
Rennes University Hospital
Phase NA
Completed
60 enrolled